These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 34783198)

  • 1. MicroRNA-411-3p inhibits bleomycin-induced skin fibrosis by regulating transforming growth factor-β/Smad ubiquitin regulatory factor-2 signalling.
    Zhang Z; Gao X; He Y; Kang Y; Jin F; Li Y; Li T; Wei Z; Li S; Cai W; Mao N; Wang S; Liu H; Yang F; Xu H; Yang J
    J Cell Mol Med; 2021 Dec; 25(24):11290-11299. PubMed ID: 34783198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN.
    Ai K; Zhu X; Kang Y; Li H; Zhang L
    Exp Mol Pathol; 2020 Feb; 112():104358. PubMed ID: 31836508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-485 Modulates the TGF-β/ Smads Signaling Pathway in Chronic Asthmatic Mice by Targeting Smurf2.
    Wang J; Li HY; Wang HS; Su ZB
    Cell Physiol Biochem; 2018; 51(2):692-710. PubMed ID: 30463065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-411-3p alleviates Silica-induced pulmonary fibrosis by regulating Smurf2/TGF-β signaling.
    Gao X; Xu H; Xu D; Li S; Wei Z; Li S; Cai W; Mao N; Jin F; Li Y; Li T; Yi X; Liu H; Yang F
    Exp Cell Res; 2020 Mar; 388(2):111878. PubMed ID: 32004504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis.
    Zerr P; Vollath S; Palumbo-Zerr K; Tomcik M; Huang J; Distler A; Beyer C; Dees C; Gela K; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2015 Mar; 74(3):e20. PubMed ID: 24448349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation.
    Cao F; Li Z; Ding WM; Yan L; Zhao QY
    Mol Med; 2019 Mar; 25(1):7. PubMed ID: 30894138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of miR-133a-3p inhibits fibrosis and proliferation of keloid fibroblasts by regulating IRF5 to inhibit the TGF-β/Smad2 pathway.
    Huang Y; Wang Y; Lin L; Wang P; Jiang L; Liu J; Wang X
    Mol Cell Probes; 2020 Aug; 52():101563. PubMed ID: 32205184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
    Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
    Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
    [No Abstract]   [Full Text] [Related]  

  • 9. Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.
    Zerr P; Palumbo-Zerr K; Huang J; Tomcik M; Sumova B; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2016 Jan; 75(1):226-33. PubMed ID: 25180292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.
    Zou M; Wang F; Gao R; Wu J; Ou Y; Chen X; Wang T; Zhou X; Zhu W; Li P; Qi LW; Jiang T; Wang W; Li C; Chen J; He Q; Chen Y
    Sci Rep; 2016 Apr; 6():24747. PubMed ID: 27098600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-322-5p targeting Smurf2 regulates the TGF-β/Smad pathway to protect cardiac function and inhibit myocardial infarction.
    Guo L; Li K; Ma Y; Niu H; Li J; Shao X; Li N; Sun Y; Wang H
    Hum Cell; 2024 Jul; 37(4):972-985. PubMed ID: 38656742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-β/Smad pathway.
    Chen Y; Zhang Q; Zhou Y; Yang Z; Tan M
    Hum Exp Toxicol; 2020 May; 39(5):683-695. PubMed ID: 31884830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-323a-3p Promotes Pressure Overload-Induced Cardiac Fibrosis by Targeting TIMP3.
    Zhang J; Lang Y; Guo L; Pei Y; Hao S; Liang Z; Su G; Shu L; Liu H; Huang C; Xu J
    Cell Physiol Biochem; 2018; 50(6):2176-2187. PubMed ID: 30415251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iguratimod inhibits skin fibrosis by regulating TGF-β1/Smad signalling pathway in systemic sclerosis.
    Xie X; Gan H; Tian J; Li F; Chen J; Wang J; Liao J; Li S
    Eur J Clin Invest; 2022 Aug; 52(8):e13791. PubMed ID: 35441708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis.
    Tomcik M; Palumbo-Zerr K; Zerr P; Sumova B; Avouac J; Dees C; Distler A; Becvar R; Distler O; Schett G; Senolt L; Distler JH
    Ann Rheum Dis; 2016 Mar; 75(3):609-16. PubMed ID: 25603829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad ubiquitination regulatory factor 2 expression is enhanced in hypertrophic scar fibroblasts from burned children.
    Zhang Z; Finnerty CC; He J; Herndon DN
    Burns; 2012 Mar; 38(2):236-46. PubMed ID: 21920670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of TGF-β/Smad signaling by the small compound HPH-15 ameliorates experimental skin fibrosis.
    Luong VH; Chino T; Oyama N; Matsushita T; Sasaki Y; Ogura D; Niwa SI; Biswas T; Hamasaki A; Fujita M; Okamoto Y; Otsuka M; Ihn H; Hasegawa M
    Arthritis Res Ther; 2018 Mar; 20(1):46. PubMed ID: 29544542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad ubiquitination regulatory factor-2 in the fibrotic kidney: regulation, target specificity, and functional implication.
    Tan R; He W; Lin X; Kiss LP; Liu Y
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1076-83. PubMed ID: 18353873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Puerarin alleviates chronic renal failure-induced pyroptosis in renal tubular epithelial cells by targeting miR-342-3p/TGF-β/SMAD axis.
    Yang J; Li B; Wang J; Fan W
    Genes Genomics; 2023 Dec; 45(12):1563-1573. PubMed ID: 37747643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor.
    Shi X; Liu Q; Li N; Tu W; Luo R; Mei X; Ma Y; Xu W; Chu H; Jiang S; Du Z; Zhao H; Zhao L; Jin L; Wu W; Wang J
    Cell Cycle; 2018; 17(16):1967-1978. PubMed ID: 30145936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.